Effects of Lisinopril, Atenolol, and Isosorbide 5-Mononitrate on Angina Pectoris and QT Dispersion in Patients with Syndrome X: An Open-Label, Randomized, Crossover Study

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Current Therapeutic Research-clinical and Experimental

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0011-393X(02)80032-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X.

  1999cited by this paper
• Increased ventricular repolarization inhomogeneity during postural changes in patients with syndrome X.

  1998cited by this paper
• Therapeutic Benefits of Cilazapril in Patients with Syndrome X

  1998cited by this paper
• Relation between QT dispersion and the extent of myocardial ischemia in patients with three-vessel coronary artery disease.

  1998cited by this paper
• Effect of atenolol on QT interval and dispersion in patients with syndrome X.

  1997cited by this paper
• Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study.

  1995cited by this paper
• Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction.

  1995cited by this paper
• Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina.

  1994cited by this paper
• QT dispersion and sudden unexpected death in chronic heart failure.

  1994cited by this paper
• Short‐and Long‐Term Reproducibility of QT, QTc, and QT Dispersion Measurement in Healthy Subjects

  1994cited by this paper
• Usefulness of changes in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X.

  1994cited by this paper
• Analysis of the electrocardiographic QT interval in patients with syndrome X.

  1994cited by this paper
• Abnormal autonomic control of the cardiovascular system in syndrome X.

  1994cited by this paper
• Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.

  1993cited by this paper
• Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease.

  1993cited by this paper
• The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries.

  1993cited by this paper
• ACE Inhibition Attenuates Sympathetic Coronary Vasoconstriction in Patients With Coronary Artery Disease

  1992cited by this paper
• Coronary adrenergic hyperreactivity in patients with syndrome X and abnormal electrocardiogram at rest.

  1991cited by this paper
• Hyperinsulinaemia and microvascular angina ("syndrome X")

  1991cited by this paper
• QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.

  1990cited by this paper
• Improved exercise capacity with acute aminophylline administration in patients with syndrome X.

  1989cited by this paper
• Syndrome X. "What's in a name...?".

  1989cited by this paper
• Comparison of verapamil versus propranolol therapy in syndrome X.

  1989cited by this paper
• Verapamil versus acebutolol for syndrome X.

  1988cited by this paper
• The nitrates and myocardial ischemia.

  1982cited by this paper
• Adrenergic effects of the QT interval of the electrocardiogram.

  1976cited by this paper
• Myocardial lactate production in patients with angina-like chest pain and angiographically normal coronary arteries and left ventricle.

  1974cited by this paper
• Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms.

  1973cited by this paper

• Treatment Modalities for Angina with Non-Obstructive Coronary Arteries (ANOCA): A Systematic Review and Meta-Analysis

  2025cites this paper
• Pharmacologic Treatment of Patients With Myocardial Ischemia With No Obstructive Coronary Artery Disease.

  2018cites this paper
• Drug Class Review: Beta Adrenergic Blockers

  2009cites this paper